Ushbu ishga iqtibos qilgan ishlar

7 ta ish

Ish: Treatment of Highly Drug-Resistant Pulmonary Tuberculosis

1. A 24-Week, All-Oral Regimen for Rifampin-Resistant Tuberculosis

   Bern-Thomas Nyang’wa, Catherine Berry, Emil Kazounis +15

   MaqolaTuberculosis Research and EpidemiologyNew England Journal of Medicine20225 iqtibos

   ABIABI:AkademIndex/openalex/2022.article.000002

2. Trends, Characteristics and Treatment Outcomes of Patients with Drug-Resistant Tuberculosis in Uzbekistan: 2013–2018

   Khasan Safaev, Nargiza Parpieva, Irina Liverko +5

   MaqolaTuberculosis Research and EpidemiologyInternational Journal of Environmental Research and Public Health20212 iqtibos

   ABIABI:AkademIndex/openalex/2021.article.000207

3. Scaling Up Molecular Diagnostic Tests for Drug-Resistant Tuberculosis in Uzbekistan from 2012–2019: Are We on the Right Track?

   Sharofiddin Yuldashev, Nargiza Parpieva, Salikhdjan Alimov +6

   MaqolaTuberculosis Research and EpidemiologyInternational Journal of Environmental Research and Public Health20212 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.262609

4. Global adoption of 6-month drug-resistant TB regimens: Projected uptake by 2026

   Aastha Gupta, Sandeep Juneja, Victor Babawale +12

   MaqolaTuberculosis Research and EpidemiologyPLoS ONE20240 iqtibos

   ABIABI:AkademIndex/openalex/2024.article.000247

5. Introducing BPaL: Experiences from countries supported under the LIFT-TB project

   D. F. Wares, M. Mbenga, Veriko Mirtskhulava +19

   MaqolaTuberculosis Research and EpidemiologyPLoS ONE20240 iqtibos

   ABIABI:AkademIndex/openalex/2024.article.000471

6. The Effectiveness and Safety of Bedaquiline, Pretomanid, and Linezolid (BPaL)–Based Regimens for Rifampicin-Resistant Tuberculosis in Non-Trial Settings—A Prospective Cohort Study in Belarus and Uzbekistan

   Animesh A. Sinha, Robert J. Klebe, Michael L. Rekart +22

   MaqolaTuberculosis Research and EpidemiologyClinical Infectious Diseases20250 iqtibos

   ABIABI:AkademIndex/openalex/2025.article.000230

7. OPTIMIZATION OF TREATMENT FOR PATIENTS WITH DRUG-RESISTANT PULMONARY TUBERCULOSIS

   Sevginoz Khodjiyeva

   MaqolaTuberculosis Research and EpidemiologyMedical science of Uzbekistan20250 iqtibos

   ABIABI:AkademIndex/openalex/2025.article.006574